Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Varicella

Treatments: Drug: Valaciclovir

Study type: Observational

Funder types: Industry

Identifiers

NCT01390857

112323

Details and patient eligibility

About

The purpose of this post-marketing surveillance study is to collect and assess information on safety and efficacy of valaciclovir in pediatric patients with chickenpox

Enrollment: 379 patients

Sex: All

Ages: Under 14 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pediatric patients with chickenpox (aged less than 15 years old).

Exclusion criteria

• Patients with a history of hypersensitivity to the ingredients of valaciclovir or acyclovir.

Trial design

379 participants in 1 patient group

Pediatric patients prescribed valaciclovir

Description:

Pediatric patients with chickenpox prescribed valaciclovir during study period.

Treatment:

Drug: Valaciclovir